検索結果

December 22, 2025 General Announcement Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a

Management Policy | About Senju | SENJU Pharmaceutical

“Being a good company” is our management policy. As a company that aims to be reliable, necessary and valuable for society, we are committed to pursuing happiness for all people associated with Senju

NewMytear CL Cool-s | OTC Products, etc. | Products | SENJU Pharmaceutical

Category 3 OTC medicines New Mytear® CL Cool-s Moisturize with cool sensation while wearing contact lenses CHARACTERISTICS This medicine can be used while wearing all types of contact lenses (hard, so

Mytear PINT CARE EX Mild | OTC Products, etc. | Products | SENJU Pharmaceutical

Category 3 OTC medicines Mytear® PINT CARE EX Mild For eyestrain and blurred vision CHARACTERISTICS Contains the maximum concentration* of neostigmine methylsulfate with a focus adjustment-improving e

MytearV | OTC Products, etc. | Products | SENJU Pharmaceutical

Category 2 OTC medicines Mytear® V Resolves redness of the eye and provides healthy and clear eyes. CHARACTERISTICS Compounded with "tetrahydrozoline hydrochloride", a component to relieve r